Cargando…
Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells
The accumulation of perturbations in signalling pathways resulting in an apoptosis-insensitive phenotype is largely responsible for the desperate prognosis of patients with pancreatic ductal adenocarcinoma (PDAC). Accumulating evidence suggests that the death receptors TRAIL-R1 and TRAIL-R2 play imp...
Autores principales: | Radke, David I., Ling, Qi, Häsler, Robert, Alp, Gökhan, Ungefroren, Hendrik, Trauzold, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267290/ https://www.ncbi.nlm.nih.gov/pubmed/30366420 http://dx.doi.org/10.3390/cancers10110399 |
Ejemplares similares
-
RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
por: Ungefroren, Hendrik, et al.
Publicado: (2019) -
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
por: Witte, David, et al.
Publicado: (2016) -
Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5
por: Zeeh, Franziska, et al.
Publicado: (2016) -
Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis
por: Ungefroren, Hendrik
Publicado: (2021) -
Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2017)